"" Clover Health Investments Corp. (NASDAQ:CLOV) Interim CFO Joseph Clay Thornton sold 17,775 shares of the company's Class A Common Stock on August 17, 2026, to cover tax withholding obligations associated with vesting restricted stock units. The total value of these sales amounted to $78,032.
The shares were sold at a weighted average price of $4.39, with individual transactions occurring within a price range of $4.29 to $4.39. These sales were not discretionary trades by Mr. Thornton, but rather part of the company's equity incentive plans, which mandate a "sell to cover" transaction for tax obligations.
Following these transactions, Mr. Thornton directly beneficially owns 1,249,526 shares of Class A Common Stock. The company has been performing well, with its second-quarter 2026 financial results surpassing Wall Street's expectations. Clover Health achieved adjusted earnings of 5 cents per share, exceeding the anticipated 4 cents per share, and revenue for the quarter reached $743.2 million, surpassing analysts' projections of $728.27 million.
Recent Developments at Clover Health
Clover Health reported its second-quarter 2026 financial results, marking a 56% increase in revenue from the previous year. The company also raised its full-year outlook, which was well-received by investors. The stock has surged 110% in the last six months, delivering a 61% return over the past year.
For deeper insights into Clover Health's financial health and future prospects, investors can access the comprehensive Pro Research Report, available for CLOV and 1,400+ other US equities on InvestingPro.